GLP-1 Becomes the Hot Marketing Target for Health Tech Brands

As adoption of GLP-1 medications like Ozempic surges, health tech companies increasingly target these users as a marketing demographic. While body composition monitoring genuinely matters for GLP-1 users facing muscle loss, manufacturers are overstating how products were 'built for' this group—a trend set to accelerate as roughly one in eight Americans now uses GLP-1 drugs.